Revolution Medicines
RVMD
RVMD
511 hedge funds and large institutions have $19.1B invested in Revolution Medicines in 2026 Q1 according to their latest regulatory filings, with 171 funds opening new positions, 164 increasing their positions, 126 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more capital invested
Capital invested by funds: $15.9B → $19.1B (+$3.19B)
3.04% less ownership
Funds ownership: 103.09% → 100.05% (-3%)
36% less call options, than puts
Call options by funds: $326M | Put options by funds: $513M
Holders
511
Holding in Top 10
46
Calls
$326M
Puts
$513M
Top Buyers
| 1 | +$330M | |
| 2 | +$231M | |
| 3 | +$223M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$210M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$177M |
Top Sellers
| 1 | -$350M | |
| 2 | -$256M | |
| 3 | -$213M | |
| 4 |
LC
Lunate Capital
Al Maryah Island, Abu Dhabi,
United Arab Emirates
|
-$166M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$155M |
